CINF vs KNSA · P/E 16, rev $7.14B vs P/E 53, rev $677.6M
Cincinnati Financial Corporation (CINF) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CINF revenue for 2026-06-30 was $7.14B. Net income was $1.53B. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the CINF and KNSA stock pages for the full models.
Not investment advice.